Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, 200 1st Street, Southwest, Rochester, MN 55905, USA.
Department of Laboratory Medicine & Pathology, Mayo Clinic College of Medicine and Science, 200 1st Street, Southwest, Rochester, MN 55905, USA.
Immunol Allergy Clin North Am. 2023 May;43(2):273-287. doi: 10.1016/j.iac.2023.01.007. Epub 2023 Mar 1.
Smoking-related interstitial lung diseases (ILDs) are a group of heterogeneous, diffuse pulmonary parenchymal disease processes associated with tobacco exposure. These disorders include pulmonary Langerhans cell histiocytosis, respiratory bronchiolitis-associated ILD, desquamative interstitial pneumonia, acute eosinophilic pneumonia, and combined pulmonary fibrosis and emphysema. This review summarizes the current evidence of pathogenesis, clinical manifestations, diagnostic approach, prognosis, and treatment modalities for these diseases. We also discuss the interstitial lung abnormalities incidentally detected in radiologic studies and smoking-related fibrosis identified on lung biopsies.
与吸烟相关的间质性肺疾病(ILDs)是一组与烟草暴露相关的异质性弥漫性肺实质疾病。这些疾病包括肺朗格汉斯细胞组织细胞增生症、呼吸性细支气管炎相关间质性肺病、脱屑性间质性肺炎、急性嗜酸性粒细胞肺炎以及肺纤维化合并肺气肿。本综述总结了这些疾病的发病机制、临床表现、诊断方法、预后和治疗方式的现有证据。我们还讨论了影像学研究中偶然发现的间质性肺异常以及肺活检中发现的与吸烟相关的纤维化。